Trial intelligence / Profile preview

Oxytocin Nasal Spray for Preventing Postoperative Delirium in Elderly Orthopedic Surgery Patients

NCT06945926Phase 2Completed

Sponsor
Zhejiang University
Start
Jun 2025
Primary completion
May 2026
Countries
1
01

Overview

A Phase 2 trial of oxytocin nasal spray in postoperative delirium (POD), sponsored by Zhejiang University. Started Jun 2025; status: completed.

02

Drugs

oxytocin nasal spray
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on NCT06945926.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06945926.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call